Action LB Pharmaceuticals - LBRX

LB Pharmaceuticals Inc (LBRX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

32,95

( -2,34% )

Prix Achat

29,84

Prix Vente

36,47

Volume échangé

186 570

Volume moyen (3 m)

US$ 264 342

Volume financier

US$ 6 083 931

31,97 Fourchette du Jour 34,205

13,36 Plage de 52 semaines 35,345

Cap du marché

944,896M

Valeur d'Entreprise

596,494M

Clôture Veille

33,74

Ouverture

33,74

Dernière Transaction

33.6

Dernière heure de transaction

VWAP

32,6094

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-38,95M

Actions en circulation

28 676 652

Flottant (%)

63,12%

Détention Institutionnelle (%)

107,99%

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-12,89

Ratio Cours/Ventes (P/S)

Bénéfice par action (BPA)

-2,59

Bêta

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute... LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York. Show more

Secteur

Health Care

Industrie

Site Web

lbpharma.us

Siège social

New York, United States

Fondé

2026

LB Pharmaceuticals Inc est coté dans le secteur Health Care de la NASDAQ avec le ticker LBRX. Le dernier cours de clôture d'LB Pharmaceuticals était de US$33,74. Au cours de la dernière année, les actions de LB Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 13,36 à US$ 35,345.

LB Pharmaceuticals compte actuellement 28 676 652 actions en circulation. La capitalisation boursière d'LB Pharmaceuticals est de US$944,90 million. LB Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -12.89.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.78	-2.3124814705	33.73	35.345	31.841	297113	33.97671948	CS
4	4.38	15.3307665383	28.57	35.345	27.37	387028	31.56873218	CS
12	4.17	14.489228631	28.78	35.345	26.37	242314	30.73083165	CS
26	11.77	55.5712936733	21.18	35.345	18.43	247686	27.21990272	CS
52	16.11	95.6650831354	16.84	35.345	13.36	246529	23.87372957	CS
156	16.11	95.6650831354	16.84	35.345	13.36	246529	23.87372957	CS
260	16.11	95.6650831354	16.84	35.345	13.36	246529	23.87372957	CS

LBRX - Frequently Asked Questions (FAQ)

What is the current LB Pharmaceuticals Inc share price?

The current share price of LB Pharmaceuticals Inc is US$ 32,95

How many LB Pharmaceuticals Inc shares are in issue?

LB Pharmaceuticals Inc has 28 676 652 shares in issue

What is the market cap of LB Pharmaceuticals Inc?

The market capitalisation of LB Pharmaceuticals Inc is USD 944,9M

What is the 1 year trading range for LB Pharmaceuticals Inc share price?

LB Pharmaceuticals Inc has traded in the range of US$ 13,36 to US$ 35,345 during the past year

What is the PE ratio of LB Pharmaceuticals Inc?

The price to earnings ratio of LB Pharmaceuticals Inc is -12,89

What is the registered address of LB Pharmaceuticals Inc?

The registered address for LB Pharmaceuticals Inc is One Pennsylvania Plaza, New York, New York, 10119

What is the LB Pharmaceuticals Inc website address?

The website address for LB Pharmaceuticals Inc is lbpharma.us

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Inc (LBRX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de LB Pharmaceuticals Inc

LBRX Dernières nouvelles

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

LB Pharmaceuticals to Participate in Upcoming June Investor Events

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

LBRX - Frequently Asked Questions (FAQ)

LBRX Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités